86 related articles for article (PubMed ID: 16185622)
1. [Myocardial bridging and fractional flow reserve].
Hernández-García JM; Alonso-Briales JH; de Teresa E
Rev Esp Cardiol; 2005 Sep; 58(9):1117. PubMed ID: 16185622
[No Abstract] [Full Text] [Related]
2. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
[TBL] [Abstract][Full Text] [Related]
3. The use of adenosine in the assessment of stable coronary heart disease.
Ripley DP; Jenkins NP; Thomas HE
J R Coll Physicians Edinb; 2019 Sep; 49(3):182-184. PubMed ID: 31497782
[No Abstract] [Full Text] [Related]
4. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.
Watkins S; McGeoch R; Lyne J; Steedman T; Good R; McLaughlin MJ; Cunningham T; Bezlyak V; Ford I; Dargie HJ; Oldroyd KG
Circulation; 2009 Dec; 120(22):2207-13. PubMed ID: 19917885
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain.
Hasdai D; Holmes DR; Higano ST; Burnett JC; Lerman A
Mayo Clin Proc; 1998 Dec; 73(12):1133-40. PubMed ID: 9868410
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve.
Schlundt C; Bietau C; Klinghammer L; Wiedemann R; Rittger H; Ludwig J; Achenbach S
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25908694
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
[TBL] [Abstract][Full Text] [Related]
8. Asystole during dipyridamole infusion in patients without coronary artery disease or beta-blocker therapy.
Frossard M; Weiss K; Gössinger H; Zeiner A; Leitha T
Clin Nucl Med; 1997 Feb; 22(2):97-100. PubMed ID: 9031766
[TBL] [Abstract][Full Text] [Related]
9. [Conservative treatment concepts for stable angina pectoris in coronary heart disease].
Schoebel FC; Leschke M; Heintzen MP; Strauer BE
Med Klin (Munich); 1996 Jul; 91(7):458-65. PubMed ID: 8756115
[No Abstract] [Full Text] [Related]
10. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
[No Abstract] [Full Text] [Related]
11. [Beta-blockers in coronary disease].
Carlier J
Rev Med Liege; 1981 Oct; 36 Suppl 1():17-25. PubMed ID: 6119755
[No Abstract] [Full Text] [Related]
12. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory.
Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM
Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981
[TBL] [Abstract][Full Text] [Related]
13. Variations of coronary hemodynamic responses to intravenous adenosine infusion: implications for fractional flow reserve measurements.
Seto AH; Tehrani DM; Bharmal MI; Kern MJ
Catheter Cardiovasc Interv; 2014 Sep; 84(3):416-25. PubMed ID: 24282074
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
[TBL] [Abstract][Full Text] [Related]
15. The changes of fractional flow reserve after intracoronary nitrate and Nicorandil injection in coronary artery ectasia.
Kim W; Jeong MH; Ahn YK; Cho JG; Park JC; Kang JC
Int J Cardiol; 2006 Nov; 113(2):250-1. PubMed ID: 16290224
[No Abstract] [Full Text] [Related]
16. Usefulness of transthoracic Doppler echocardiography for noninvasive assessment of coronary blood flow in a patient with symptomatic myocardial bridging.
Inaba S; Okayama H; Higashi H; Nishimura K; Inoue K; Ogimoto A; Higaki J
Eur J Echocardiogr; 2011 Mar; 12(3):E15. PubMed ID: 20980327
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effect of myocardial bridging.
Kersemans M; Van Heuverswyn F; De Pauw M; Gheeraert P; Taeymans Y; Drieghe B
Circ Cardiovasc Interv; 2009 Aug; 2(4):361-2. PubMed ID: 20031741
[No Abstract] [Full Text] [Related]
18. Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.
Micari A; Belcik TA; Balcells EA; Powers E; Wei K; Kaul S; Lindner JR
Am J Cardiol; 2005 Nov; 96(10):1410-5. PubMed ID: 16275189
[TBL] [Abstract][Full Text] [Related]
19. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
[TBL] [Abstract][Full Text] [Related]
20. Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil--a case report.
Dillon WC; Hadian D; Ritchie ME
Angiology; 2001 Feb; 52(2):137-41. PubMed ID: 11228087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
